Relationship between commonly defined metabolic health phenotypes and obesity with lung function in a working population: A cross-sectional study

被引:1
作者
Guzman-Garcia, Jose-Miguel [1 ]
Romero-Saldana, Manuel [1 ,2 ,4 ]
Molina-Recio, Guillermo [1 ,2 ]
Alvarez-Fernandez, Carlos [1 ,3 ]
Jimenez-Merida, Maria del Rocio
Molina-Luque, Rafael [1 ,2 ]
机构
[1] Univ Cordoba, Fac Med & Nursing, Dept Nursing Pharmacol & Physiotherapy, Cordoba 14004, Spain
[2] Maimonides Biomed Res Inst Cordoba IMIBIC, Lifestyles Innovat & Hlth Res Associate Grp, Cordoba 14004, Spain
[3] Cordoba City Council, Dept Occupat Hlth & Safety, Huerto San Pedro Real, Cordoba, Spain
[4] Univ Cordoba, Avd Menendez Pidal No No, Cordoba 14004, Spain
来源
HEART & LUNG | 2024年 / 67卷
关键词
Lung disease; Obesity; Metabolism; Lung function test; NATIONAL-HEALTH; DETERMINANTS; DIAGNOSIS;
D O I
10.1016/j.hrtlng.2024.04.017
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Four phenotypes relate metabolism and obesity: metabolically healthy (MHO) and unhealthy (MUO) people with obesity and metabolically healthy (MHNO) and unhealthy (MUNO) people without obesity. No studies have addressed the association between these categories and lung function in the working population. Objectives: The aim was to determine the relationship of phenotypes to lung ageing as measured by lung age and its relationship to lung dysfunction. Methods: A descriptive cross-sectional study was conducted in a working population. The outcome variable was lung function assessed by lung age. The four phenotypes of obesity and metabolic health (MHNO, MHO, MUO and MUNO) were determined using NCEP-ATP III criteria. Lung dysfunctions were classified into restrictive, obstructive, and mixed patterns. Results: The mean age of the participants was 43.7 years, ranging from 18 to 67 years. Of the 1860 workers, 51.3 % were women. The prevalences found were 71.4 %, 12 %, 10.6 % and 6 % for MHNO, MUO, MHO, and MUNO, respectively. MHO ( beta = 0.66; p = 0.591) was not associated with increased lung ageing compared with MHNO, but MUO ( beta = 7.1; p < 0.001) and MUNO ( beta = 6.6; p < 0.001) were. Concerning pulmonary dysfunctions, MUNO (OR = 1.93; p < 0.001) and MUO (OR = 2.91; p < 0.001) were found to be related to the presence of a restrictive pattern, and MUNO (OR = 2.40; p = 0.028) to the mixed pattern. Conclusion: The results show that metabolic abnormalities, not obesity, are responsible for premature lung ageing and, therefore, lung function decline. In our study, having obesity without metabolic abnormality was not significantly associated with the presence of dysfunctional respiratory patterns.
引用
收藏
页码:62 / 69
页数:8
相关论文
共 47 条
  • [1] [Anonymous], 2005, Guidelines for data processing and analysis of the international physical activity questionnaire (IPAQ) - Short and long forms
  • [2] Metabolic Syndrome and the Lung
    Baffi, Cynthia W.
    Wood, Lisa
    Winnica, Daniel
    Strollo, Patrick J., Jr.
    Gladwin, Mark T.
    Que, Loretta G.
    Holguin, Fernando
    [J]. CHEST, 2016, 149 (06) : 1525 - 1534
  • [3] Chronic obstructive pulmonary disease
    Barnes, Peter J.
    Burney, Peter G. J.
    Silverman, Edwin K.
    Celli, Bartolome R.
    Vestbo, Jorgen
    Wedzicha, Jadwiga A.
    Wouters, Emiel F. M.
    [J]. NATURE REVIEWS DISEASE PRIMERS, 2015, 1
  • [4] Metabolically Healthy Obesity
    Blueher, Matthias
    [J]. ENDOCRINE REVIEWS, 2020, 41 (03) : 405 - 420
  • [5] Callaway C, 1998, Anthropometric Standardization Reference Manual, V4445th
  • [6] Castrejon-Vazquez M, 2014, Rev Alerg Mex, V61, P305
  • [7] Relationship between Lung Function and Metabolic Syndrome
    Chen, Wei-Liang
    Wang, Chung-Ching
    Wu, Li-Wei
    Kao, Tung-Wei
    Chan, James Yi-Hsin
    Chen, Ying-Jen
    Yang, Ya-Hui
    Chang, Yaw-Wen
    Peng, Tao-Chun
    [J]. PLOS ONE, 2014, 9 (10):
  • [8] Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III)
    Cleeman, JI
    Grundy, SM
    Becker, D
    Clark, LT
    Cooper, RS
    Denke, MA
    Howard, WJ
    Hunninghake, DB
    Illingworth, DR
    Luepker, RV
    McBride, P
    McKenney, JM
    Pasternak, RC
    Stone, NJ
    Van Horn, L
    Brewer, HB
    Ernst, ND
    Gordon, D
    Levy, D
    Rifkind, B
    Rossouw, JE
    Savage, P
    Haffner, SM
    Orloff, DG
    Proschan, MA
    Schwartz, JS
    Sempos, CT
    Shero, ST
    Murray, EZ
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 285 (19): : 2486 - 2497
  • [9] Lifetime spirometry patterns of obstruction and restriction, and their risk factors and outcomes: a prospective cohort study
    Dharmage, Shyamali C.
    Bui, Dinh S.
    Walters, Eugene H.
    Lowe, Adrian J.
    Thompson, Bruce
    Bowatte, Gayan
    Thomas, Paul
    Garcia-Aymerich, Judith
    Jarvis, Debbie
    Hamilton, Garun S.
    Johns, David P.
    Frith, Peter
    Senaratna, Chamara, V
    Idrose, Nur S.
    -Baker, Richard R. Wood
    Hopper, John
    Gurrin, Lyle
    Erbas, Bircan
    Washko, George R.
    Faner, Rosa
    Agusti, Alvar
    Abramson, Michael J.
    Lodge, Caroline J.
    Perret, Jennifer L.
    [J]. LANCET RESPIRATORY MEDICINE, 2023, 11 (03) : 273 - 282
  • [10] The effect of obesity on lung function
    Dixon, Anne E.
    Peters, Ubong
    [J]. EXPERT REVIEW OF RESPIRATORY MEDICINE, 2018, 12 (09) : 755 - 767